Dr. Margolis testifies at FDA hearing on mesh complications
On 9/8/11 Dr. Margolis was invited by the FDA to testify during its Hearing for the Obstetrics and Gynecology Devices Panel on complications caused by transvaginal mesh for pelvic prolapse and stress incontinence. To read Dr. Margolis' testimony click here.
Dr. Margolis continues to applaud the FDA for its correct stance on this important health care issue. Furthermore, he hopes that the American Congress of Ob/Gyns, American Urologic Association, American Urogynecologic Society, the Society of Gynecologic Surgeons and his professional colleagues will join him in promoting excellence in women's pelvic surgery by supporting a rapid change in the use of synthetic mesh used in transvaginal surgery
